Leonel Rojo, Ph.D.
Affiliations: | Rutgers University, New Brunswick, New Brunswick, NJ, United States |
Area:
NeuropharmacologyGoogle:
"Leonel Rojo"Mean distance: 15.06 (cluster 33) | S | N | B | C | P |
Parents
Sign in to add mentor| Ricardo Benjamin Maccioni | grad student | University of Chile | ||
| (Now at U. Santiago, Chile) | ||||
| Rodrigo Orlando Kuljiš | grad student | 2006-2008 | University of Miami | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Andrade V, Wong-Guerra M, Cortés N, et al. (2023) Scaling the Andean Shilajit: A Novel Neuroprotective Agent for Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland). 16 |
| Wong-Guerra M, Calfio C, Maccioni RB, et al. (2023) Revisiting the neuroinflammation hypothesis in Alzheimer's disease: a focus on the druggability of current targets. Frontiers in Pharmacology. 14: 1161850 |
| Calfio C, Gonzalez A, Singh SK, et al. (2020) The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad |
| Andrade V, Cortés N, Pastor G, et al. (2020) N-Acetyl Cysteine and Catechin-Derived Polyphenols: A Path Toward Multi-Target Compounds Against Alzheimer's Disease. Journal of Alzheimer's Disease : Jad |
| Kuljiš RO, Colom LV, Rojo LE. (2013) Biological basis for cerebral dysfunction in schizophrenia in contrast with Alzheimer's disease. Frontiers in Psychiatry. 4: 119 |
| Rojo LE, Gaspar PA, Maccioni RB. (2011) Molecular targets in the rational design of AD specific PET tracers: tau or amyloid aggregates? Current Alzheimer Research. 8: 652-8 |
| Rojo LE, Alzate-Morales J, Saavedra IN, et al. (2010) Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 19: 573-89 |
| Maccioni RB, Rojo LE, Fernández JA, et al. (2009) The role of neuroimmunomodulation in Alzheimer's disease. Annals of the New York Academy of Sciences. 1153: 240-6 |
| Maccioni RB, Farias GA, Rojo LE, et al. (2009) What have we learned from the tau hypothesis? Current Hypotheses and Research Milestones in Alzheimer's Disease. 49-62 |
| Rojo LE, Fernández J, Jiménez J, et al. (2009) Central nervous system inflammation and cholesterol metabolism alterations in the pathogenesis of Alzheimer's disease and their diagnostic and therapeutic implications Current Hypotheses and Research Milestones in Alzheimer's Disease. 125-137 |